Latest News
-
PharmaTag monitors critical drugs during transportation
European based company Dyzle (www.Dyzle.com) is launching its new leading edge solution for the pharmaceutical industry – the PharmaTag. The approach is simple: a thin measuring device, the size of a credit card, travels with the product during its…
Latest News | 07 September 2011
-
BioAlliance Pharma presents orphan drug survival results at international liver cancer congress
BioAlliance Pharma SA announces oral communication of the phase 2 clinical trial results of its orphan product Livatag at the annual congress of ILCA (International Liver Cancer Association). Prof Philippe Merle, Professor of hepatology at the Hos…
Latest News | 06 September 2011
-
Novartis drug Afinitor gains EU approval
Novartis announced that the European Commission has approved Afinitor (everolimus) tablets for the treatment of unresectable or metastatic, well- or moderately-differentiated neuroendocrine tumors (NET) of pancreatic origin in adults with progressive…
Latest News | 05 September 2011
-
Puracyp and Promega combine cell lines and assay systems
Puracyp Inc and Promega Corporation have teamed up to provide all-inclusive kits to assess nuclear receptor activation, P450 metabolism, and cellular toxicity during the drug development process. These whole cell assay systems will identify compounds…
Latest News | 02 September 2011
-
AllCells expands operations in Shanghai, China
AllCells LLC announced that it has completed the relocation and operational expansion of its Shanghai-based facilities. AllCells-Shanghai is now situated in Ju Ke Park near the center of the city with almost 10,000 sq ft of laboratory, production…
Latest News | 02 September 2011
-
AstraZeneca announces top-line results from SATURN study
AstraZeneca has announced top-line results from SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN). SATURN was designed to measure the impact of CRESTOR (rosuvastatin) 40 mg and atorvastatin 80…
Latest News | 02 September 2011
-
NuGEN announces exclusive partnership with Advanced Liquid Logic
NuGEN Technologies Inc and Advanced Liquid Logic announced an exclusive co-development and supply agreement under which Advanced Liquid Logic will provide instrumentation, software and digital microfluidic cartridge technology to NuGEN for commercial…
Latest News | 31 August 2011
-
ICON selected as provider for early phase clinical development by BMS
ICON plc announced that it has been chosen by Bristol-Myers Squibb as a preferred provider for full-service clinical pharmacology and exploratory clinical studies. This latest agreement with Bristol-Myers-Squibb follows the company’s selection of I…
Latest News | 30 August 2011
-
Novartis International BioCamp spotlights diversity
Novartis has opened its eighth annual International Biotechnology Leadership Camp (BioCamp), a three-day seminar bringing biotechnology and business experts together with 60 selected students from leading international universities in 24 countries an…
Latest News | 29 August 2011
-
Abbott receives FDA approval for ALK gene test for lung cancer therapy selection
Abbott announced it has received approval from the US Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC). The new…
Latest News | 27 August 2011
